InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Dowden Nathan J, Chief Operating Officer. Officer active across 1 company, notably Entrada Therapeutics, Inc.. Aggregated, 26 filings have been published. Breakdown: 0 buy · 14 sells. Total volume traded: €558k. Activity tracked since 1 March 2022. The latest transaction was filed on 4 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dowden Nathan J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
15,000 shares@ US$1.740.0090% mcap16.0% of flowCommon StockSEC:0001873392-26-000004:0
3,116 shares@ US$13.0245.6% of flowCommon StockSEC:0001873392-26-000002:0
55,800 shares0Common StockSEC:0001873392-26-000001:0
1,746 shares@ US$5.43021.4% of flowCommon StockSEC:0001873392-25-000003:0
60,800 shares0Common StockSEC:0001689375-25-000013:0
847 shares@ US$16.002.0% of flowCommon StockSEC:0001689375-24-000056:0
399 shares@ US$15.19470.9% of flowCommon StockSEC:0001689375-24-000054:0
483 shares@ US$15.76111.1% of flowCommon StockSEC:0001689375-24-000051:0
20,000 shares@ US$1.745.2% of flowCommon StockSEC:0001689375-24-000048:0
1,826 shares@ US$12.32133.4% of flowCommon StockSEC:0001689375-24-000007:0
33,100 shares0Common StockSEC:0001689375-24-000004:0
14,200 shares0Common StockSEC:0001689375-23-000061:0
3,200 shares@ US$18.00168.6% of flowCommon StockSEC:0001689375-23-000047:0
8,885 shares@ US$14.935720.1% of flowCommon StockSEC:0001689375-23-000042:0
14,200 shares0Common StockSEC:0001689375-23-000026:0
28,400 shares0Common StockSEC:0001689375-23-000012:0
2,100 shares@ US$24.04538.4% of flowCommon StockSEC:0001689375-22-000040:0
3,034 shares@ US$20.104310.1% of flowCommon StockSEC:0001689375-22-000038:0
905 shares@ US$18.07352.8% of flowCommon StockSEC:0001689375-22-000036:0
1,329 shares@ US$15.323.5% of flowCommon StockSEC:0001689375-22-000032:0
3,275 shares@ US$15.12588.3% of flowCommon StockSEC:0001689375-22-000029:0
100 shares@ US$15.010.2% of flowCommon StockSEC:0001689375-22-000027:0
912 shares@ US$15.14722.3% of flowCommon StockSEC:0001689375-22-000018:0
5,632 shares0Common StockSEC:0001104659-22-097873:0
7,714 shares@ US$13.000.038% mcap68.0% of flowCommon StockSEC:0001104659-22-075788:0
25 of 26 declarations
About Dowden Nathan J
Dowden Nathan J is Directeur des Opérations and President & COO at Entrada Therapeutics, Inc. The 26 filings on record all relate to Entrada Therapeutics, Inc., with 0 in purchases and 557675 in sales over the sampled period from 2022-03-03 to 2026-05-04, and the modal transaction nature is Sale.
